Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
BJU International
Published October 4, 2026
Gleason pattern 4 length and active surveillance eligibility in Grade Group 2-4 prostate cancer.
October 5, 2026
Medspoke
Medspoke
Journal of Clinical Endocrinology & Metabolism (JCEM)
Published October 5, 2026
00:00
--:--
Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk.
October 5, 2026
Share
Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk.
https://www.medspoke.co/channel_journal?id=680&tap_id=15048
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
European Heart Journal
Published October 5, 2026
Deep vein thrombosis exacerbated by syndecan-4 shedding and piezo1-dependent endothelial-mesenchy...
October 5, 2026
Why are you reporting this TALK?